Tofajak XR 11 mg Tofajak XR 11 mg contains Tofacitinib 11 mg in an extended-release formulation that provides a controlled release of the medicine throughout the day. It is used to manage autoimmune diseases by helping regulate an overactive immune response, thereby reducing inflammation and relieving symptoms such as joint pain, swelling, stiffness, and reduced mobility. The once-daily extended-release tablet offers convenient dosing for patients with conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. It should be used only under the supervision of a qualified healthcare professional.